Melanoma: open trials in Switzerland

14 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
Trial Treatment · Phase 2 · Swiss Cancer Institute
Universitätsspital Basel, Basel · Ente Ospedaliero Cantonale (EOC), Bellinzona · Inselspital Bern, Bern · HFR Fribourg, Fribourg · Hôpitaux Universitaires de Genève (HUG), Geneva · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne · Spital Thurgau (Kantonsspital Münserlingen und Frauenfeld), Münsterlingen · HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen · Universitätsspital Zürich USZ, Zurich
Registry updated 2026-10-27
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Kantonsspital Graubunden, Chur · Universitätsspital Zürich, Zurich
Registry updated 2026-10-06
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.
Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne
Registry updated 2026-09-24
NCT07740642
A Comparative Usability Study of Two Total Body Skin Imaging Systems
Trial Treatment · University Hospital, Basel, Switzerland
University Hospital Basel, Basel
Registry updated 2026-08-03
NCT06889766
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Trial Treatment · Phase 1 · Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois, Lausanne · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Registry updated 2026-05-15
NCT07015190
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Trial Treatment · Phase 3 · IDEAYA Biosciences
Universitätsspital Basel, Basel · Universitätsspital Zürich, Zurich
Registry updated 2026-05-06
NCT05522660
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · ETOP IBCSG Partners Foundation
Inselspital, Bern · Kantonsspital Winterthur, Winterthur · Universitätsspital Zürich, Zurich
Registry updated 2026-04-27
NCT07492121
Screening for Brain Metastases
Trial Treatment · Phase 2 · University of Zurich
University Hospital Zurich, Zurich
Registry updated 2026-03-25
NCT05549297
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Trial Treatment · Phase 3 · Immunocore Ltd
Kantonsspital St. Gallen, Sankt Gallen · Universitaetsspital Zürich, Zurich
Registry updated 2026-02-25
NCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Trial Treatment · Phase 3 · Immunocore Ltd
UniversitaetsSpital Zuerich - Dermatologische Klinik, Zurich
Registry updated 2026-02-25
NCT03567889
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Trial Treatment · Phase 3 · Philogen S.p.A.
Universitätsspital Basel, Basel · Istituto Oncologico della Svizzera Italiana, Bellinzona · Insel Gruppe AG, Bern · Hôpitaux universitaires de Genève, Geneva · Kantonsspital St. Gallen, Sankt Gallen · Universitätsspital Zürich USZ, Zurich
Registry updated 2025-12-17
NCT06384053
Skin Cancer and Hyperthermia and Radiotherapy
Trial Treatment · Kantonsspital Winterthur KSW
Kantonsspital Aarau, Aarau · Lindenhofgruppe, Bern · Luzerner Kantonsspital, Lucerne · Kantonsspital Winterthur, Winterthur
Registry updated 2025-06-15
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Inselspital, Bern · Universitaetsspital Zürich, Zurich
Registry updated 2024-08-26
NCT04045691
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Research · Pierre Fabre Pharma GmbH
38, Aarau · 52, Bellinzona · 37, Bern · 24, Chur · 36, Lausanne · 58, Lucerne · 26, Winterthur · 25, Zurich
Registry updated 2021-01-19

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error